Skip to content

Alamar Biosciences ALMR Accrued expenses and other liabilities

Accrued expenses and other liabilities at other companies

Affirm Holdings, Inc. logo
Affirm Holdings, Inc.AFRM
$217.94M+25.5%
UBS
United BanksharesUBSI
$267.01M+5.0%
EFC
Ellington Financial Inc.EFC
$57.88M+36.3%
MFA Financial logo
MFA FinancialMFA
$332.64M+6.0%
Cigna logo
CignaCI
$8.98B+11.8%
PNC Financial Services logo
PNC Financial ServicesPNC
$14.21B+1.8%

Other financials

Income statement

See full
Revenue$26.0M+98.9%
Gross profit$14.5M+126%
Operating income-$12.3M-44.4%
Net income-$21.3M-178%
EPS (diluted)-$1.74-156%

Balance sheet

See full
Cash & equivalents$64.6M
Total debt$30.6M
Total equity-$178.1M
Total assets$186.5M

Cash flow

See full
Operating cash flow-$20.3M-55.7%
CapEx$600.0K+8.3%
Free cash flow-$20.9M-53.8%

Valuation

See full
Market cap$1.52B
Enterprise value$1.49B

Returns & leverage

See full
Debt / equity-0.2×
Current ratio5.9×

Where this comes from

Reported directly by Alamar Biosciences in its filing.

Tagged under the XBRL concept us-gaap:AccruedLiabilitiesAndOtherLiabilities.

The official record: Alamar Biosciences ’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Alamar Biosciences 's accrued expenses and other liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Alamar Biosciences 's accrued expenses and other liabilities?
Alamar Biosciences (ALMR) reported accrued expenses and other liabilities of $16.81M in Q1 2026.